New drug combo aims to tackle tough lymphoma
Disease control
Ongoing
This early-stage trial tests the safety and correct dose of combining two cancer drugs, loncastuximab tesirine and venetoclax, for people with non-Hodgkin lymphoma that has come back or not responded to treatment. About 23 adults will take part. The goal is to find a safe dose an…
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated May 17, 2026 09:27 UTC